Impact of Subsidy on the Use of Personalized Medicine in Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of Subsidy on the Use of Personalized Medicine in Breast Cancer

Published:2022-05 Issue: Volume:29 Page:108-115
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Lim Jue Tao,Koh Jemima Jia En,Ho Peh Joo,Liu Jenny,Lim Swee Ho,Tan Ern Yu,Tan Benita Kiat Tee,Tan Veronique Kiak Mien,Tan Su Ming,Yong Wei Sean,Hartman Mikael,Chen Cynthia

Funder

Ministry of Education - Singapore

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference23 articles.

1. Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden;Chia;Int J Cancer,2005

2. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer;Piccart-Gebhart;N Engl J Med,2005

3. Adjuvant trastuzumab in HER2-positive breast cancer;Slamon;N Engl J Med,2011

4. Barriers to the use of personalized medicine in breast cancer;Weldon;J Oncol Pract,2012

5. Parliament: breast cancer patients who received unnecessary treatments to receive full refund by KTPH;Khalik,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP